Form D · Private Equity Fund
Blackstone Life Sciences VI L.P.
New York, NY · CIK 0002023640
Offering snapshot reported Apr 2, 2026 · SEC filing
- Reported sold
- $6.3B Offering amount: $6.3B
- Investors reported
- 119 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 18, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$3,615,298,293 → $6,300,000,000
- Reported investors69 → 119
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 2, 2026 | Amendment | $6,300,000,000 | $2,684,701,707vs Dec 9, 2025 | 119 | SEC filing |
| Dec 9, 2025 | Amendment | $3,615,298,293 | $322,461,800vs Oct 8, 2025 | 69 | SEC filing |
| Oct 8, 2025 | Amendment | $3,292,836,493 | $1,499,798,893vs Apr 23, 2025 | 67 | SEC filing |
| Apr 23, 2025 | Amendment | $1,793,037,600 | No comparison | 49 | SEC filing |
| Dec 17, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $15.2M
- Finders' fees
- $0
- Form D file number
- 021-532359
Total Amount Sold includes the General Partner's commitment as well as sales in parallel funds and sales made under Regulation S.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Compass Group Global Advisors S.A. | None | |
| Raymond James & Associates, Inc. | 705 | |
| Raymond James Financial Services Inc. | 6694 | |
| Morgan Stanley Smith Barney LLC | 149777 | |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 7691 | |
| iCapital Markets LLC | 118219 | |
| UBS Financial Services Inc. | 8174 |
Source: Form D, filed Apr 2, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
BLACKSTONE LIFE SCIENCES VI L.P.
Investment adviser: BLACKSTONE LIFE SCIENCES ADVISORS L.L.C.
- Gross asset value
- $3.76B
- Beneficial owners
- 86
- ADV minimum commitment
- $10M
Reported in Form ADV on Mar 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- No
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- No
- External marketing
- Yes
Filing source
Form ADV 2068503 · Mar 30, 2026 · Schedule D 7.B.(1), fund 805-7806102113
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Baratta | Executive |
| N/A Blackstone Life Sciences Associates Vi L.P. | Promoter |
| N/A Bxls Vi L.L.C. | Promoter |
| Julie Constable | Executive |
| Mathias Favetto | Executive |
| John G. Finley | Executive |
| Nicholas Galakatos | Executive |
| Elsa Gelin | Executive |
| Ilan Halal | Executive |
| Tabea Hsi | Executive |
| Natacha Jamar | Executive |
| Eric Liaw | Executive |
| Robert Liptak | Executive |
| Nentcho Nentchev | Executive |
| Alicia Novak | Executive |
| Chris Placca | Executive |
| Victoria Portnoy | Executive |
| Omar Rehman | Executive |
| Christopher Striano | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10154